by The Tutu Team | Sep 8, 2017 | Uncategorized
Author: Barbara Jacoby / Source: Let Life Happen From: PR Newswire — Breakthrough Therapy designation received for the treatment of patients with HER2-positive, locally advanced or metastatic breast cancer who have been treated with trastuzumab and... 
by The Tutu Team | Sep 5, 2017 | Uncategorized
Source: OncLive Although drugs that target HER2 have transformed the prognosis for many patients with breast cancer, the development of resistant disease remains a significant clinical challenge. Dual blockade strategies have become a new standard of care for HER2-... 